The therapeutic potential of mesenchymal stem cells

Bibliography

• ASAHARA T, MASUDA H, TAKAHASHI T et al.: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. (1999) 85(3):221-228.
   PubMed Web of Science ®Google Scholar
• COLTER DC, CLASS R, DIGIROLAMO CM, PROCKOP DJ: Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc. Natl. Acad. Sci. USA (2000) 97(7):3213-3218.
   PubMed Web of Science ®Google Scholar
• BRUDER SP, JAISWAL N, HAYNESWORTH SE: Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell Biochem. (1997) 64(2):278-294.
   PubMed Web of Science ®Google Scholar
• DENNIS JE, MERRIAM A, AWADALLAH A et al.: A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J. Bone Miner. Res. (1999) 14(5):700-709.
   PubMed Web of Science ®Google Scholar
• PROCKOP DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science (1997) 276(5309):71-74.
   PubMed Web of Science ®Google Scholar
• YOO JU, BARTHEL TS, NISHIMURA K et al.: The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J. Bone Joint Surg. Am. (1998) 80(12):1745-1757.
   PubMed Web of Science ®Google Scholar
• FERRARI G, CUSELLA-DE ANGELIS G, COLETTA M et al.: Muscle regeneration by bone marrow-derived myogenic progenitors. Science (1998) 279(5356):1528-1530.
   PubMed Web of Science ®Google Scholar
• GALMICHE MC, KOTELIANSKY VE, BRIERE J, HERVE P, CHARBORD P: Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood (1993) 82(1):66-76.
   PubMed Web of Science ®Google Scholar
• ROMANOV YA, SVINTSITSKAYA VA, SMIRNOV VN: Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells (2003) 21(1):105-110.
   PubMed Web of Science ®Google Scholar
• ZUK PA, ZHU M, ASHJIAN P et al.: Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell (2002) 13(12):4279-4295.
   PubMed Web of Science ®Google Scholar
• KERN S, EICHLER H, STOEVE J, KLUTER H, BIEBACK K: Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells (2006) 24(5):1294-1301.
   PubMed Web of Science ®Google Scholar
• FUKUCHI Y, NAKAJIMA H, SUGIYAMA D et al.: Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells (2004) 22(5):649-658.
   PubMed Web of Science ®Google Scholar
• DA SILVA MEIRELLES L, CHAGASTELLES PC, NARDI NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. (2006) 119(Part 11):2204-2213.
   PubMed Web of Science ®Google Scholar
• LE BLANC K, TAMMIK C, ROSENDAHL K, ZETTERBERG E, RINGDEN O: HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. (2003) 31(10):890-896.
   PubMed Web of Science ®Google Scholar
• BERRY MF, ENGLER AJ, WOO YJ et al.: Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am. J. Physiol. Heart Circ. Physiol. (2006) 290(6):H2196-H2203.
   PubMed Web of Science ®Google Scholar
• GNECCHI M, HE H, NOISEUX N et al.: Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. Faseb J. (2006) 20(6):661-669.
   PubMed Web of Science ®Google Scholar
• GNECCHI M, HE H, LIANG OD et al.: Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. (2005) 11(4):367-368.
   PubMed Web of Science ®Google Scholar
• TANG YL, TANG Y, ZHANG YC et al.: Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J. Am. Coll. Cardiol. (2005) 46(7):1339-1350.
   PubMed Web of Science ®Google Scholar
• KIM SW, HAN H, CHAE GT et al.: Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells (2006) 24(6):1620-1626.
   PubMed Web of Science ®Google Scholar
• CHEN J, LI Y, WANG L et al.: Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke (2001) 32(4):1005-1011.
   PubMed Web of Science ®Google Scholar
• WANG L, LI Y, CHEN X et al.: MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology (2002) 7(2):113-117.
   PubMedGoogle Scholar
• HELLMANN MA, PANET H, BARHUM Y, MELAMED E, OFFEN D: Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci. Lett. (2006) 395(2):124-128.
   PubMed Web of Science ®Google Scholar
• GRUNBLATT E, MANDEL S, YOUDIM MB: Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP. Ann. NY Acad. Sci. (2000) 899:262-273.
   PubMed Web of Science ®Google Scholar
• LEVY YS, MERIMS D, PANET H et al.: Induction of neuron-specific enolase promoter and neuronal markers in differentiated mouse bone marrow stromal cells. J. Mol. Neurosci. (2003) 21(2):121-132.
   PubMed Web of Science ®Google Scholar
• ISAKOVA IA, BAKER K, DUFOUR J, GAUPP D, PHINNEY DG: Preclinical evaluation of adult stem cell engraftment and toxicity in the CNS of rhesus macaques. Mol. Ther. (2006) 13(6):1173-1184.
   PubMed Web of Science ®Google Scholar
• LI Y, CHEN J, ZHANG CL et al.: Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia (2005) 49(3):407-417.
   PubMed Web of Science ®Google Scholar
• YAMADA Y, UEDA M, NAIKI T et al.: Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng. (2004) 10(5-6):955-964.
   PubMedGoogle Scholar
• UEDA M, YAMADA Y, OZAWA R, OKAZAKI Y: Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement. Int. J. Periodontics Restorative Dent. (2005) 25(2):129-137.
   PubMed Web of Science ®Google Scholar
• GRONTHOS S, MANKANI M, BRAHIM J, ROBEY PG, SHI S: Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. USA (2000) 97(25):13625-13630.
   PubMed Web of Science ®Google Scholar
• GRONTHOS S, BRAHIM J, LI W et al.: Stem cell properties of human dental pulp stem cells. J. Dent. Res. (2002) 81(8):531-535.
   PubMed Web of Science ®Google Scholar
• YAMADA Y, FUJIMOTO A, ITO A, YOSHIMI R, UEDA M: Cluster analysis and gene expression profiles: a cDNA microarray system-based comparison between human dental pulp stem cells (hDPSCs) and human mesenchymal stem cells (hMSCs) for tissue engineering cell therapy. Biomaterials (2006) 27(20):3766-3781.
   PubMed Web of Science ®Google Scholar
• FRIEDMAN MS, LONG MW, HANKENSON KD: Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J. Cell Biochem. (2006) 98(3):538-554.
   PubMed Web of Science ®Google Scholar
• PEREIRA RF, O'HARA MD, LAPTEV AV et al.: Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc. Natl. Acad. Sci. USA (1998) 95(3):1142-1147.
   PubMed Web of Science ®Google Scholar
• HORWITZ EM, PROCKOP DJ, GORDON PL et al.: Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood (2001) 97(5):1227-1231.
   PubMed Web of Science ®Google Scholar
• HORWITZ EM, GORDON PL, KOO WK et al.: Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. USA (2002) 99(13):8932-8937.
   PubMed Web of Science ®Google Scholar
• OHGUSHI H, KOTOBUKI N, FUNAOKA H et al.: Tissue engineered ceramic artificial joint-ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials (2005) 26(22):4654-4661.
   PubMed Web of Science ®Google Scholar
• WAKITANI S, IMOTO K, YAMAMOTO T et al.: Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr. Cartil. (2002) 10(3):199-206.
   PubMed Web of Science ®Google Scholar
• STUDENY M, MARINI FC, CHAMPLIN RE et al.: Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors. Cancer Res. (2002) 62(13):3603-3608.
   PubMed Web of Science ®Google Scholar
• STUDENY M, MARINI FC, DEMBINSKI JL et al.: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl. Cancer Inst. (2004) 96(21):1593-1603.
   PubMed Web of Science ®Google Scholar
• MENON LG, PICINICH S, KONERU R et al.: Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells (2006).
   PubMedGoogle Scholar
• HUNG SC, DENG WP, YANG WK et al.: Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin. Cancer Res. (2005) 11(21):7749-7756.
   PubMed Web of Science ®Google Scholar
• DJOUAD F, PLENCE P, BONY C et al.: Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood (2003) 102(10):3837-3844.
   PubMed Web of Science ®Google Scholar
• KHAKOO AY, PATI S, ANDERSON SA et al.: Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J. Exp. Med. (2006) 203(5):1235-1247.
   PubMed Web of Science ®Google Scholar
• KRAMPERA M, GLENNIE S, DYSON J et al.: Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood (2003) 101(9):3722-3729.
   PubMed Web of Science ®Google Scholar
• RINGDEN O, UZUNEL M, RASMUSSON I et al.: Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation (2006) 81(10):1390-1397.
   PubMed Web of Science ®Google Scholar
• MIYAHARA Y, NAGAYA N, KATAOKA M et al.: Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. (2006) 12(4):459-465.
   PubMed Web of Science ®Google Scholar
• KATRITSIS DG, SOTIROPOULOU PA, KARVOUNI E et al.: Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc. Interv. (2005) 65(3):321-329.
   PubMed Web of Science ®Google Scholar
• DAI W, HALE SL, MARTIN BJ et al.: Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation (2005) 112(2):214-223.
   PubMed Web of Science ®Google Scholar
• PIAO H, YOUN TJ, KWON JS et al.: Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium. Eur. J. Heart Fail. (2005) 7(5):730-738.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO R, OMURA T, YOSHIYAMA M et al.: Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol. (2005) 25(6):1168-1173.
   PubMed Web of Science ®Google Scholar
• CRIGLER L, ROBEY RC, ASAWACHAICHARN A, GAUPP D, PHINNEY DG: Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp. Neurol. (2006) 198(1):54-64.
   PubMed Web of Science ®Google Scholar
• BANG OY, LEE JS, LEE PH, LEE G: Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. (2005) 57(6):874-882.
   PubMed Web of Science ®Google Scholar
• HANABUSA K, NAGAYA N, IWASE T et al.: Adrenomedullin enhances therapeutic potency of mesenchymal stem cells after experimental stroke in rats. Stroke (2005) 36(4):853-858.
   PubMed Web of Science ®Google Scholar
• ZHANG H, HUANG Z, XU Y, ZHANG S: Differentiation and neurological benefit of the mesenchymal stem cells transplanted into the rat brain following intracerebral hemorrhage. Neurol. Res. (2006) 28(1):104-112.
   PubMed Web of Science ®Google Scholar
• QI M, HU J, ZOU S, ZHOU H, HAN L: Mandibular distraction osteogenesis enhanced by bone marrow mesenchymal stem cells in rats. J. Craniomaxillofac. Surg. (2006) 34(5):283-289.
   PubMed Web of Science ®Google Scholar
• LE BLANC K, GOTHERSTROM C, RINGDEN O et al.: Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation (2005) 79(11):1607-1614.
   PubMed Web of Science ®Google Scholar
• LEE OK, COATHUP MJ, GOODSHIP AE, BLUNN GW: Use of mesenchymal stem cells to facilitate bone regeneration in normal and chemotherapy-treated rats. Tissue Eng. (2005) 11(11-12):1727-1735.
   PubMedGoogle Scholar
• QUARTO R, MASTROGIACOMO M, CANCEDDA R et al.: Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. (2001) 344(5):385-386.
   PubMed Web of Science ®Google Scholar
• KYRIAKOU CA, YONG KL, BENJAMIN R et al.: Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. J. Gene Med. (2006) 8(3):253-264.
   PubMed Web of Science ®Google Scholar
• KOMAROVA S, KAWAKAMI Y, STOFF-KHALILI MA, CURIEL DT, PEREBOEVA L: Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol. Cancer Ther. (2006) 5(3):755-766.
   PubMed Web of Science ®Google Scholar